Government Programs Summit 2014

Now in its 6th year, the GP Summit keeps you informed on rapidly changing reporting requirements, and provides the tools to ensure correct pricing calculations to achieve compliance excellence in Government Programs. The GP Summit has 14 seasoned state and federal government officials represented on the speaking faculty along with industry rebate experts who represent large, mid-sized and small pharmaceutical and generics manufacturers. This event is designed to share collective understanding of each program, including: new calculation methodologies, how healthcare reform will impact government programs and a clear view on how the program can work well, with solutions to challenges.


Speakers
Jonathan Karl, Chief White House Correspondent, ABC News
Stan Dorn, Senior Fellow, Urban Institute Health Policy Center
Miree Lee, MS, MBA, Bio|Pharma Pricing & Contracts Consultant, M. Lee Consulting, LLC
Robert LaPorte, Director, Government Reporting & Compliance, West-Ward Pharmaceuticals
Josh O'Harra, Assistant General Counsel, Eli Lilly & Co.
John Shakow, Partner, King & Spalding
Christopher Hatwig, MS, RPh, FASHP, President, APEXUS, 340B Prime Vendor Program
Lisa C. McNair, Manager, Government Pricing & Contracting, Reckitt Benckiser Pharmaceuticals
David Buckley, Contract Operations Mgr, Contract Management and Operations US, GlaxoSmithKline
Heather Dixson, Director, Government Price Reporting, Lilly USA
and many more...